We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

Vapor System Obliterates Obstructive Prostate Tissue

By HospiMedica International staff writers
Posted on 31 Jan 2018
Print article
Image: Transurethral vapor technology treats benign prostate hyperplasia (Photo courtesy of NxThera).
Image: Transurethral vapor technology treats benign prostate hyperplasia (Photo courtesy of NxThera).
A new minimally invasive system uses the natural thermal energy stored in steam to treat benign prostatic hyperplasia (BPH).

The NxThera (Maple Grove, MN, USA) Rezūm System is based on convective water vapor energy (WAVE) platform technology, which is designed to treat BPH symptoms such as frequency, urgency, irregular flow, weak stream, and straining by delivering steam into targeted prostate tissue. When the water vapor contacts the tissue it condenses, releasing the stored thermal energy, causing the obstructive prostate tissue cells to die. In the weeks following a Rezūm procedure, the body's natural healing response eliminates the treated tissue, shrinking the prostate.

The transurethral thermal therapy can be performed in a clinic or out-patient setting using the simple hand-held device, which delivers radiofrequency (RF) generated thermal therapy, in the form of water vapor, directly to the enlarged, obstructive prostate tissue. As the extra tissue is removed, the urethra opens back up, reducing BPH symptoms and improving the patient's quality of life. The system also allows men to retain sexual function, unlike surgical BPH treatments, which typically have higher incidences of long-term sexual side effects.

“Studies have documented that 60% of men discontinue use of drug therapy to treat BPH after one year as a result of side effects, including sexual dysfunction, and lower degrees of symptom relief and quality of life,” said Bob Paulson, president and CEO of NxThera. “Rezūm offers a cost-effective BPH treatment option, providing durable and compelling symptom relief, without sexual dysfunction, which allow men to resume their quality of life, balanced with an efficient use of health care spending.”

More than half of all men in their sixties and as many as 90% of men in their seventies and eighties have some symptoms of BPH such as more frequent urination with hesitant, interrupted, or weak stream and urgency and leaking. Severe BPH can lead to more serious problems over time, such as strain on the bladder, urinary tract infections, bladder or kidney damage, bladder stones, and incontinence. Current treatment options to relieve symptoms associated with BPH include drug therapy or surgical procedures, including removal of the enlarged part of the prostate.

Related Links:

Gold Member
12-Channel ECG
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
24.5-inch Full HD 2D OLED Medical Monitor

Print article


Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.